 BRIDGEWATER, N.J., May 05, 2022 GLOBE NEWSWIRE -- Hillstream BioPharma, Inc. NASDAQ: HILS Hillstream or the Company, a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers, announced that it is scheduled to present at BioNJs 12th Annual BioPartnering Virtual Conference , taking place Monday, May 9, 2022, to Friday, May 13, 2022. 